A Study of the Natural History of Shoulder Pathology in Manual Wheelchair Users

Overview

About this study

The purpose of this study is to follow the development of shoulder disease in manual wheelchair users, associated with the cumulative exposure to elevated shoulder postures and high upper body loading.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Inclusion Criteria:

Group 1 (Manual Wheelchair User Cohort):

  • Participants who use a manual wheelchair as the primary mode of mobility.
  • 18 – 70 years of age.
  • Functional upper extremity range of motion.
  • Willingness to participate in study.
  • Ability to return to receive shoulder MRI 1-3 times/year, and once per year receive physical exam, and strength assessments.

Group 2 (Age and Sex-matched Able-bodied Cohort):

  • 18-70 years of age.
  • Able to walk independently with no reliance on an orthotic, prosthetic, or gait aid.
  • Functional upper extremity range of motion.
  • Willingness to participate in study.
  • Ability to receive shoulder MRI 1-3 times/year, and once per year receive physical exam, and strength assessments.

Exclusion Criteria: 

Group1 (Manual Wheelchair User Cohort):

  • Previous diagnosis of bilateral shoulder tendon tears prior to spinal cord injury or suspected tendon tears with physical exam.
  • They have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence.

Group 2 (Matched Able-bodied Cohort):

  • Any documented musculoskeletal or neurological disorders that would be expected to impact shoulder health or change ability to walk independently.
  • Previous diagnosis of shoulder tears prior to enrollment or suspected tendon tears with physical exam.
  • They have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Melissa Morrow, Ph.D.

Open for enrollment

Contact information:

Meegan Van Straaten P.T.

(507)255-0694

VanStraaten.Meegan@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20167665

Mayo Clinic Footer